Argus to pay $37M in DOJ case over misused regulator data
By 
Jeff Dale2024-03-12T20:59:00
Economic data and research firm Argus Information and Advisory Services agreed to pay $37 million to settle charges from the Department of Justice (DOJ) alleging misuse of data obtained through federal regulatory contracts.
Argus was tasked with validating, aggregating, storage, retrieval, and reporting services for anonymized credit card data that regulatory agencies directed banks to provide but broke its contract by misusing the data to create proxy data it incorporated into products and services sold to commercial customers, the DOJ said in a press release Tuesday.
Argus will pay $13.5 million in restitution to the United States under the False Claims Act, plus interest, according to its settlement agreement. The company settled without admitting or denying liability but did deny it knowingly took part in the alleged misconduct.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefDOJ orders Hahn Air to pay $27M over travel fee false claims
Hahn Air Lines and its U.S. subsidiary agreed to pay $26.8 million to settle alleged violations of the False Claims Act over knowingly failing to provide remittance for travel fees it collected from commercial airline passengers flying into or within the United States.
-
News BriefConsolidated Nuclear Security to pay $18.4M over timecard false claims
Consolidated Nuclear Security agreed to pay $18.4 million to settle alleged False Claims Act violations regarding the submission of timecards for unworked hours to the National Nuclear Security Administration.
-
News BriefGamma Healthcare, owners to pay $13.6M in DOJ false claims case
Missouri-based Gamma Healthcare and three of its owners agreed to pay approximately $13.6 million to settle charges levied by the Department of Justice of violating the False Claims Act by improperly billing Medicare for tests that were not ordered or medically necessary.
More from Regulatory Enforcement
-
ArticleSFO head to step down as speculation grows over future of agency
Nick Ephgrave, director of the U.K.’s main anti-corruption enforcement agency, the Serious Fraud Office, will retire at the end of March—about halfway through his appointed five-year term. Experts say he leaves the agency in a lot better position than he joined it in September 2023.
-
News BriefFTC puts GM’s puts connected vehicle data practices under compliance spotlight
The U.S. Federal Trade Commission finalized its order against General Motors and its OnStar subsidiary over the improper usage of geolocation and driving behavior data of drivers.
-
ArticleKaiser plans pay $556M to settle Medicare upcoding allegations
Kaiser Health affiliates have agreed to pay more than $556 million to settle allegations originally made by whistleblowers that they ignored compliance department warnings and unlawfully reworked diagnoses for Medicare patients in order to receive higher payments from the federal government.